SEC Filings

SEC Filings

Filing date Form Description Filing Group View
CT ORDER

CT ORDER

Other
View HTML
DEFM14A

Definitive proxy statement relating to merger or acquisition

Mergers & Acquisitions
View HTML
DRS

Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

Registration Statements
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML
EFFECT

EFFECT

Other
View HTML

Data provided by Kaleidoscope.

IR Contact

Novartis Investor Relations

investor.relations@novartis.com

 

MEDIA CONTACT

Novartis Media Relations

media.relations@novartis.com